Microsoft: A Critical Point in Valuation Momentum
May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions
May 22, 2025 Are you making these mistakes when analyzing candlestick patterns?
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
Gilead Sciences (GILD) stock forecast for 2026
Updated: May 23, 2025 (06:02)
Sector: HealthcareThe share price of Gilead Sciences, Inc. (GILD) now
50/200 Day Moving Average: $105.95 / $94.31
This figure corresponds to the Average Price over the previous 50/200 days. For Gilead Sciences stocks, the 50-day moving average is the resistance level today.
For Gilead Sciences stocks, the 200-day moving average is the resistance level today.
Are you interested in Gilead Sciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Gilead Sciences stock price in 2026. How much will one Gilead Sciences share be worth in 2026? Is it worth taking profit / loss on GILD stock now or waiting? What are analysts' forecasts for Gilead Sciences stock?
We forecast Gilead Sciences stock performance using neural networks based on historical data on GILD stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Gilead Sciences, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Gilead Sciences analysts is $115.04. Today 200 Day Moving Average is the support level (94.31 $). 50 Day Moving Average is the resistance level (105.95 $).
Historical and forecast chart of Gilead Sciences, Inc. stock
The chart below shows the historical price of Gilead Sciences stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the GILD stock price can be found in the table below.
Gilead Sciences is an American biopharmaceutical company that discovers, develops and markets innovative medicines. For many years since the firm opened, they have specialized mainly in antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C and influenza. The company is headquartered in Foster City, California, but has offices in North America, Europe and Australia.
Gilead Sciences was founded in June 1987 by a young physician, Michael Riordan. Michael worked with three key scientific advisors to start the company – Peter Derwan of the California Institute of Technology, Doug Melton of Harvard, and Harold Weintraub of the Fred Hutchinson Cancer Research Center. Riordan served as CEO from inception until 1996. He was most interested in the antiviral business, as he contracted dengue himself. In 2006, the company made two acquisitions, which allowed it to expand into not only antiviral drugs, but also drugs in the field of cardiovascular and respiratory diseases.
Gilead Sciences (GILD) Forecast for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 111.58 | 109.23 | 114.42 | 4.54 % |
| Feb | 111.07 | 107.46 | 114.57 | 6.20 % |
| Mar | 113.46 | 110.17 | 115.84 | 4.90 % |
| Apr | 110.74 | 108.41 | 111.96 | 3.16 % |
| May | 109.80 | 106.83 | 112.71 | 5.21 % |
| Jun | 110.95 | 106.68 | 115.17 | 7.37 % |
| Jul | 114.89 | 112.65 | 117.93 | 4.48 % |
| Aug | 115.35 | 113.68 | 118.00 | 3.67 % |
| Sep | 112.75 | 108.64 | 116.14 | 6.46 % |
| Oct | 113.88 | 112.57 | 115.13 | 2.23 % |
| Nov | 114.51 | 112.90 | 116.63 | 3.19 % |
| Dec | 112.33 | 108.91 | 114.30 | 4.72 % |
Gilead Sciences information and performance
333 LAKESIDE DR, FOSTER CITY, CA, US
Market capitalization of the Gilead Sciences, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GILD shares in the company outstanding by the market price of one share.
EBITDA of Gilead Sciences is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Gilead Sciences price target for 2026 by month
Target values for the price of one Gilead Sciences share for Jan 2026.
In Jan, the Negative dynamics for Gilead Sciences, Inc. shares will prevail with possible monthly volatility of 4.535% volatility is expected.
Pessimistic target level: 109.23
Optimistic target level: 114.42
Target values for the price of one Gilead Sciences share for Feb 2026.
In Feb, the Negative dynamics for Gilead Sciences, Inc. shares will prevail with possible monthly volatility of 6.205% volatility is expected.
Pessimistic target level: 107.46
Optimistic target level: 114.57
Target values for the price of one Gilead Sciences share for Mar 2026.
In Mar, the Positive dynamics for Gilead Sciences, Inc. shares will prevail with possible monthly volatility of 4.897% volatility is expected.
Pessimistic target level: 110.17
Optimistic target level: 115.84
Target values for the price of one Gilead Sciences share for Apr 2026.
In Apr, the Negative dynamics for Gilead Sciences, Inc. shares will prevail with possible monthly volatility of 3.165% volatility is expected.
Pessimistic target level: 108.41
Optimistic target level: 111.96
Target values for the price of one Gilead Sciences share for May 2026.
In May, the Negative dynamics for Gilead Sciences, Inc. shares will prevail with possible monthly volatility of 5.213% volatility is expected.
Pessimistic target level: 106.83
Optimistic target level: 112.71
Target values for the price of one Gilead Sciences share for Jun 2026.
In Jun, the Positive dynamics for Gilead Sciences, Inc. shares will prevail with possible monthly volatility of 7.370% volatility is expected.
Pessimistic target level: 106.68
Optimistic target level: 115.17
Target values for the price of one Gilead Sciences share for Jul 2026.
In Jul, the Positive dynamics for Gilead Sciences, Inc. shares will prevail with possible monthly volatility of 4.481% volatility is expected.
Pessimistic target level: 112.65
Optimistic target level: 117.93
Target values for the price of one Gilead Sciences share for Aug 2026.
In Aug, the Positive dynamics for Gilead Sciences, Inc. shares will prevail with possible monthly volatility of 3.665% volatility is expected.
Pessimistic target level: 113.68
Optimistic target level: 118.00
Target values for the price of one Gilead Sciences share for Sep 2026.
In Sep, the Negative dynamics for Gilead Sciences, Inc. shares will prevail with possible monthly volatility of 6.456% volatility is expected.
Pessimistic target level: 108.64
Optimistic target level: 116.14
Target values for the price of one Gilead Sciences share for Oct 2026.
In Oct, the Positive dynamics for Gilead Sciences, Inc. shares will prevail with possible monthly volatility of 2.225% volatility is expected.
Pessimistic target level: 112.57
Optimistic target level: 115.13
Target values for the price of one Gilead Sciences share for Nov 2026.
In Nov, the Positive dynamics for Gilead Sciences, Inc. shares will prevail with possible monthly volatility of 3.191% volatility is expected.
Pessimistic target level: 112.90
Optimistic target level: 116.63
Target values for the price of one Gilead Sciences share for Dec 2026.
In Dec, the Negative dynamics for Gilead Sciences, Inc. shares will prevail with possible monthly volatility of 4.718% volatility is expected.
Pessimistic target level: 108.91
Optimistic target level: 114.30
Gilead Sciences (GILD) stock dividend
Gilead Sciences last paid dividends on 06/13/2025. The next scheduled payment will be on 06/27/2025. The amount of dividends is $3.1 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
Related stocks from Healthcare sector
